Recent research conducted by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the journal Nature.
It has long been thought that prolonged COVID-19 infections in immunocompromised individuals may have been the source of the multiple new variants that arose during the coronavirus pandemic and seeded successive waves of infection, including the Alpha and Omicron variants. But until now, the prevalence of persistent COVID-19 infections in the general population and how the virus evolves in these situations remained unknown.
Study Methodology and Findings
To investigate this, the researchers used data from the Office for National Statistics Covid Infection Survey (ONS-CIS), which tested participants approximately monthly. Of the 90,000+ participants, 3,603 provided two or more positive samples between November 2020 to August 2022 where the virus was sequenced. Of these, 381 individuals tested positive for the same viral infection over a period of a month or longer. Within this group, 54 individuals had a persistent infection that lasted at least two months. The researchers estimate that between one in a thousand to one in 200 (0.1-0.5%) of all infections may become persistent, and last for at least 60 days.
In some cases, individuals remained infected with viral variants that had gone extinct in the general population. In contrast, the researchers found that reinfection with the same variant was very rare, likely due to the host developing immunity to that variant and the variant reducing in frequency to very low levels after a few months.
Insights into Viral Dynamics and Long-COVID
Of the 381 persistent infections, 65 had three or more PCR tests taken over the course of their infection. Most (82%) of these individuals demonstrated rebounding viral dynamics, experiencing high, then low, then high viral load dynamics. According to the researchers, this demonstrates that the virus can maintain the ability to actively replicate during prolonged infections.
In the study, people with persistent infections were 55% more likely to report having Long COVID symptoms more than 12 weeks since the start of the infection than people with more typical infections.
Certain individuals showed an extremely high number of mutations, including mutations that define new coronavirus variants, alter target sites for monoclonal antibodies, and introduce changes to the coronavirus spike protein. However, most individuals did not harbor a large number of mutations, suggesting that not every persistent infection will be a potential source for new concerning variants.
Co-lead author of the study Dr Mahan Ghafari (Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford) said: ‘Our observations highlight the continuing importance of community-based genomic surveillance both to monitor the emergence and spread of new variants, but also to gain a fundamental understanding of the natural history and evolution of novel pathogens and their clinical implications for patients.’
Co-lead author Dr Katrina Lythgoe (Department of Biology and Pandemic Sciences Institute, University of Oxford) said: ‘Although the link between viral persistence and Long Covid may not be causal, these results suggest persistent infections could be contributing to the pathophysiology of Long Covid. Indeed, many other possible mechanisms have been suggested to contribute to Long Covid including inflammation, organ damage, and microthrombosis.’
Reference: “Prevalence of persistent SARS-CoV-2 in a large community surveillance study” by Mahan Ghafari, Matthew Hall, Tanya Golubchik, Daniel Ayoubkhani, Thomas House, George MacIntyre-Cockett, Helen R. Fryer, Laura Thomson, Anel Nurtay, Steven A. Kemp, Luca Ferretti, David Buck, Angie Green, Amy Trebes, Paolo Piazza, Lorne J. Lonie, Ruth Studley, Emma Rourke, Darren L. Smith, Matthew Bashton, Andrew Nelson, Matthew Crown, Clare McCann, Gregory R. Young, Rui Andre Nunes dos Santos, Zack Richards, Mohammad Adnan Tariq, Roberto Cahuantzi, Wellcome Sanger Institute COVID-19 Surveillance Team, COVID-19 Infection Survey Group, The COVID-19 Genomics UK (COG-UK) Consortium, Jeff Barrett, Christophe Fraser, David Bonsall, Ann Sarah Walker and Katrina Lythgoe, 21 February 2024, Nature.
DOI: 10.1038/s41586-024-07029-4
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.
2 Comments
This is what you get, as Geert Vanden Bossche has vainly tried to explain to a deaf-eared political and medical establishment, what you get for vaccinating billions of people in the middle of a global pandemic. He also pointed out, as is mentioned in passing in this article, the dangers of multiple and prolonged infections eventually producing a mutation far more lethal than anything we have seen so far. Had this never occured to the criminal cartel responsible for the frankenjabs’ rollout and assuring us the serum was “safe and effective”?
Geert Vanden Bossche is way ahead of you “intellects”. If you trusted Fauci’s science you are probably well and truly f’ed. It is insane the level of blindness!